Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov software revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-07T21:52:06.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The record history now shows the page revision as v3.7.0, replacing the previous v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-16T22:20:19.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The record history now shows a new revision tag v3.6.6. The previous revision v3.6.5 is removed, signaling an update to the page's revision metadata rather than content changes.
    Difference
    0.1%
    Check dated 2026-09-02T19:32:58.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.5, was added to the history, replacing the previous Revision: v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-12T09:20:02.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision updated in the history from v3.6.3 to v3.6.4, reflecting a new site release in the record history. It does not modify any study information.
    Difference
    0.1%
    Check dated 2026-07-21T22:55:19.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    A new page revision entry for v3.6.3 is added to the study record history, replacing the previous v3.6.0, indicating a page-wide update rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-06-30T03:16:35.000Z thumbnail image

Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.